Literature DB >> 9072912

Angelman syndrome in adulthood.

L A Laan1, A T den Boer, R C Hennekam, W O Renier, O F Brouwer.   

Abstract

We studied the clinical and EEG-findings in 28 adult patients (aged 20-53 years) with Angelman syndrome (AS). Twenty-three showed a maternal chromosome 15q11-13 deletion; in 5, the diagnosis was based on a combination of typical clinical findings. Compared to the clinical manifestations present in childhood, "coarsening" of facial traits (100%), thoracic scoliosis (71%), and being wheelchair-bound (39%) were found more frequently. Paroxysms of laughter were still observed in adulthood (79%), but less frequently than in childhood. Most adult patients could feed themselves, but needed help with many daily activities. The majority (82%) had epileptic seizures. Abnormal EEG-activity consisting of 2-3/s rhythmic triphasic waves of high amplitude with a maximum over the frontal regions, which has been identified in many AS children, was found in 67% of these adult patients.

Entities:  

Mesh:

Year:  1996        PMID: 9072912     DOI: 10.1002/(SICI)1096-8628(19961218)66:3<356::AID-AJMG21>3.0.CO;2-K

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  20 in total

1.  Angelman syndrome: Mutations influence features in early childhood.

Authors:  Wen-Hann Tan; Carlos A Bacino; Steven A Skinner; Irina Anselm; Rene Barbieri-Welge; Astrid Bauer-Carlin; Arthur L Beaudet; Terry Jo Bichell; Jennifer K Gentile; Daniel G Glaze; Lucia T Horowitz; Sanjeev V Kothare; Hye-Seung Lee; Mark P Nespeca; Sarika U Peters; Trilochan Sahoo; Dean Sarco; Susan E Waisbren; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2011-01       Impact factor: 2.802

2.  Incontinence in persons with Angelman syndrome.

Authors:  C Wagner; J Niemczyk; M Equit; L Curfs; A von Gontard
Journal:  Eur J Pediatr       Date:  2016-12-20       Impact factor: 3.183

3.  Brief Report: A Longitudinal Study of Excessive Smiling and Laughing in Children with Angelman Syndrome.

Authors:  Dawn Adams; Kate Horsler; Rebecca Mount; Chris Oliver
Journal:  J Autism Dev Disord       Date:  2015-08

4.  Parental view of epilepsy in Angelman syndrome: a questionnaire study.

Authors:  M Ruggieri; M A McShane
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 5.  [Anesthesia and Angelman syndrome].

Authors:  W Witte; C Nobel; J Hilpert
Journal:  Anaesthesist       Date:  2011-03-16       Impact factor: 1.041

Review 6.  Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes.

Authors:  Louisa Kalsner; Stormy J Chamberlain
Journal:  Pediatr Clin North Am       Date:  2015-04-22       Impact factor: 3.278

Review 7.  Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.

Authors:  Renzo Guerrini; Romeo Carrozzo; Roberta Rinaldi; Paolo Bonanni
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome.

Authors:  Lee Koyavski; Julia Panov; Lilach Simchi; Prudhvi Raj Rayi; Lital Sharvit; Yonatan Feuermann; Hanoch Kaphzan
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

9.  SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome.

Authors:  Gregor D Gilfillan; Kaja K Selmer; Ingrid Roxrud; Raffaella Smith; Mårten Kyllerman; Kristin Eiklid; Mette Kroken; Morten Mattingsdal; Thore Egeland; Harald Stenmark; Hans Sjøholm; Andres Server; Lena Samuelsson; Arnold Christianson; Patrick Tarpey; Annabel Whibley; Michael R Stratton; P Andrew Futreal; Jon Teague; Sarah Edkins; Jozef Gecz; Gillian Turner; F Lucy Raymond; Charles Schwartz; Roger E Stevenson; Dag E Undlien; Petter Strømme
Journal:  Am J Hum Genet       Date:  2008-03-13       Impact factor: 11.025

Review 10.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.